Evidence map›Paper›PMID 29173519›Full record

ReviewGastroenterology clinics of North America2017

Diet as a Therapeutic Option for Adult Inflammatory Bowel Disease.

Samir Kakodkar, Ece A Mutlu

Abstract readReview
In one paragraph

Review in Gastroenterology clinics of North America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Samir KakodkarDivison of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, 420 East Superior Street, Chicago, IL 60611, USA.
Ece A MutluDivision of Digestive Diseases & Nutrition, Rush University Medical Center, 1725 West Harrison Street, Suite 206, Chicago, IL 60612, USA. Electronic address: Ece_Mutlu@rush.edu.

Funding

Diet modulation of bacterial sulfur & bile acid metabolism and colon cancer riskR01CA204808 · NCI · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI GASKINS, REX, MUTLU, ECE A. · 2016 to 2020
$2.0M
Dietary Treatment of Crohn's DiseaseR21AT001628 · NCCIH · RUSH UNIVERSITY MEDICAL CENTER · PI MUTLU, ECE A. · 2005 to 2007
$562k
NCCIH NIH HHS R21 AT001628NCI NIH HHS R01 CA204808
6 · The paper itself

Abstract

There are many mechanisms to explain how food may drive and ameliorate inflammation. Although there are no consistent macronutrient associations inflammatory bowel disease (IBD) development, many exclusion diets have been described: IgG-4 guided exclusion diet; semivegetarian diet; low-fat, fiber-limited exclusion diet; Paleolithic diet; Maker's diet; vegan diet; Life without Bread diet; exclusive enteral nutrition (EEN), the Specific Carbohydrate Diet (SCD) and the low FODMAP diet. The literature on diet and IBD is reviewed with a particular focus on EEN, SCD, and low FODMAP diets. Lessons learned from the existing observations and strengths and shortcomings of existing data are presented.

Indexed as

DietAdultDietary CarbohydratesDietary FatsDietary FiberDietary ProteinsEnteral NutritionFood AdditivesHumansInflammatory Bowel DiseasesMicronutrientsVitamin D DeficiencyDietary CarbohydratesDietary FatsDietary FiberDietary ProteinsFood AdditivesMicronutrientsCrohn’s diseaseDietExclusive enteral nutritionInflammatory bowel diseaseLow FODMAP dietSpecific carbohydrate dietUlcerative colitis

Identifiers

PMID29173519
PMCPMC5821251

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.